Advertisement

Articles

FDA Approves Lucentis for Diabetic Macular Edema

Genentech, a member of the Roche Group, today announced that Lucentis® (ranibizumab injection) was approved by the U.S. Food & Drug Administration (FDA) for treatment of diabetic macular edema (DME), an eye condition in...

Read More

Fostering Open Patient-Physician Communication

The American Board of Internal Medicine Foundation has launched Choosing Wisely, an initiative that encourages physicians and patients to communicate openly and ensure that appropriate care is provided at the right time without...

Read More

A Look at Specialty Drug Insurance

Healthy people appear to be willing to pay high insurance premiums for generous coverage of specialty drugs. A survey showed that respondents were willing to pay, in effect, $2.58 in generous specialty drug coverage for every...

Read More

For latest news and updates
Email-id is invalid